Mireya Velázquez-Paniagua

Mireya Velázquez-Paniagua

Auto-generated profile, based on publicly available information

Mireya Velázquez-Paniagua

Physiology Department, Medicine School, National University of Mexico, Ciudad de México 04500, Mexico

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Pharmacological Reports
Verified
Journal Article
Closed access
LVLuz X. Vásquez-Bochm
Luz X. Vásquez-Bochm
MVMireya Velázquez-Paniagua
Mireya Velázquez-Paniagua
SCSandra S. Castro-Vázquez
Sandra S. Castro-Vázquez
SGSandra L. Guerrero-Rodríguez
Sandra L. Guerrero-Rodríguez
AMAbimael Mondragon-Peralta
Abimael Mondragon-Peralta
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez

29 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Laura Gómez-VirgilioLaura Gómez-Virgilio
Laura Gómez-Virgilio
MVMireya Velazquez-Paniagua
Mireya Velazquez-Paniagua
LCLucero Cuazozon-Ferrer
Lucero Cuazozon-Ferrer
Maria-del-Carmen Silva-LuceroMaria-del-Carmen Silva-Lucero
Maria-del-Carmen Silva-Lucero
AGAndres-Ivan Gutierrez-Malacara
Andres-Ivan Gutierrez-Malacara
Maria-del-Carmen Cardenas-AguayoMaria-del-Carmen Cardenas-Aguayo
Maria-del-Carmen Cardenas-Aguayo
This review article focuses on von Hippel–Lindau (VHL) disease, a rare genetic disorder characterized by the development of tumors and cysts throughout the body. It discusses the following aspects of the disease. Genetics: VHL disease is caused by mutations in the VHL tumor suppressor gene located on chromosome 3. These mutations can be inherited or occur spontaneously. This article details the different types of mutations and their associated clinical features. Pathophysiology: The underlying cause of VHL disease is the loss of function of the VHL protein (pVHL). This protein normally regulates hypoxia-inducible factors (HIFs), which are involved in cell growth and survival. When pVHL is dysfunctional, HIF levels become elevated, leading to uncontrolled cell growth and tumor formation. Clinical Manifestations: VHL disease can affect various organs, including the brain, spinal cord, retina, kidneys, pancreas, and adrenal glands. Symptoms depend on the location and size of the tumors. Diagnosis: Diagnosis of VHL disease involves a combination of clinical criteria, imaging studies, and genetic testing. Treatment: Treatment options for VHL disease depend on the type and location of the tumors. Surgery is the mainstay of treatment, but other options like radiation therapy may also be used. Challenges: This article highlights the challenges in VHL disease management, including the lack of effective therapies for some tumor types and the need for better methods to monitor disease progression. In conclusion, we emphasize the importance of ongoing research to develop new and improved treatments for VHL disease.

1 December 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
BPBertha Prieto-Gómez
Bertha Prieto-Gómez
MVMireya Velázquez-Paniagua
Mireya Velázquez-Paniagua
LCLeonora Olivos Cisneros
Leonora Olivos Cisneros
CRCruz Reyes-Vázquez
Cruz Reyes-Vázquez
FJFrancisco Jiménez-Trejo
Francisco Jiménez-Trejo
GGGabriel Gutiérrez-Ospina
Gabriel Gutiérrez-Ospina

28 December 2018 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ARAngel J. Ruiz-Moreno
Angel J. Ruiz-Moreno
PTPatricia Torres-Barrera
Patricia Torres-Barrera
MVMireya Velázquez-Paniagua
Mireya Velázquez-Paniagua
ADAlexander Dömling
Alexander Dömling
Marco Velasco-VelazquezMarco Velasco-Velazquez
Marco Velasco-Velazquez
Background: Human cancer cell lines are valuable models for anti-cancer drug development. Although all cancer cells share common biological features, each cancer cell line has unique genotypic/ phenotypic characteristics that affect drug response. Thus, the information obtained with a specific cancer cell line cannot be easily extrapolated to other cancer cells. Consequently, cell line selection during experimental design is critical for providing proper and clinically relevant structure-activity analysis. Methods: Herein, we critically review the use of cancer cell lines as tools for activity analysis by comparing two different scenarios: i) the use of multiple cancer cell lines, with the NCI-60 Program as the most representative example; and, ii) the selection of a single cell line with specific biological characteristics that match the rationale of compound design. Results: Considering that most laboratories evaluate the activity of new compounds using few cell lines, we provide a systematic strategy for selection based on the expression levels and genetic status of the target and the effectiveness of target inhibition or silencing. We exemplify the use of public databases for data retrieval and analysis as well as the critical comparison of such information with published results. Conclusion: This approach refines cell line selection, avoiding the perpetuation of published poor selection and enhancing the relevance of the results.

10 January 2025 in Revista de la Facultad de Medicina
Verified
Journal Article
Closed access
MVMireya Velázquez-Paniagua
Mireya Velázquez-Paniagua
MGMargarita Gomez-Chavarin
Margarita Gomez-Chavarin
RSRaúl Sampieri-Cabrera
Raúl Sampieri-Cabrera
Chronic stress in humans is a silent condition that contributes to the development of physiological alterations, which can lead to disease. Among the pathologies associated with chronic stress are cardiovascular and cerebrovascular diseases, metabolic and inflammatory disorders. These, in turn, are linked to the development of metabolic syndrome, obesity, fatty liver disease, and type 2 diabetes. A relationship has also been identified with certain psychotic and neurodegenerative disorders, as well as some types of cancer. Given the clinical, social, and mental significance of chronic stress, various interventions exist to mitigate it, among which mindfulness-based programs have proven effective in reducing chronic stress across different populations. The objective of this narrative review is to provide an overview of the physiology of stress and chronic stress and to explain how the latter affects humans, from systemic alterations to central imbalances (such as memory, learning, and emotional dysregulation). Additionally, this review aims to delve into the origins and foundations of mindfulness practice and its contribution as a health intervention. Keywords: Mindfulness; regulation; chronic stress; brain; human physiology.

10 April 2025 in Toxics
Verified
Journal Article
Open access
PDF file
MGMargarita Gomez-Chavarin
Margarita Gomez-Chavarin
PPPatricia Padilla
Patricia Padilla
MVMireya Velázquez-Paniagua
Mireya Velázquez-Paniagua
Current studies suggest that environmental toxins may play a significant role in the fetal origins of Parkinson’s disease (PD). Significant evidence from animal experiments has demonstrated that these toxins can disrupt fetal neurodevelopment. PD is a neurodegenerative disorder related to the loss of dopaminergic neurons in the substantia nigra pars compacta (S. nigra) and accumulation of α-synuclein (α-syn) in the brain. Parkinson’s disease has long been associated with an idiopathic etiology, with environmental or ontogenetic factors as causes; however, the list of causal agents continues to expand as their effects are investigated at different stages of development. To explore the potential ontogenetic origins of PD, we exposed female rats subcutaneously (s.c.) to 1 mg/kg of the pesticide rotenone (ROT)—21 days during gestation, 21 days of breastfeeding, or 42 days in both periods—and assessed its long-term effects on their pups in adulthood. Our findings reveal that ROT exposure induces the degeneration of dopaminergic neurons in the S. nigra of adult rats. We administered ROT to dams during specific developmental stages and examined the nigrostriatal pathway and its functionality in offspring upon reaching young adulthood. Our results showed that perinatal ROT exposure led to (1) diminished motor skills, (2) greater concentrations of α-syn in the caudate nucleus (C. nucleus) and S. nigra, (3) reduced numbers of tyrosine hydroxylase immunoreactive neurons, and (4) hypomethylation of global 5-methylcytosine DNA compared to control rats at 60 days of age. The effects were more pronounced in rats exposed to ROT in utero and in both the in utero and breastfeeding periods, with fewer effects observed in those exposed only during breastfeeding. Thus, our findings suggest that exposure to ROT during the early developmental stages predisposes rats to Parkinsonian symptoms later in adulthood.